TY - JOUR
T1 - Health technology assessment for the acute and preventive treatment of migraine
T2 - A position statement of the International Headache Society
AU - Diener, Hans Christoph
AU - Ashina, Messoud
AU - Durand-Zaleski, Isabelle
AU - Kurth, Tobias
AU - Lantéri-Minet, Michel
AU - Lipton, Richard B.
AU - Ollendorf, Daniel A.
AU - Pozo-Rosich, Patricia
AU - Tassorelli, Cristina
AU - Terwindt, Gisela
N1 - Publisher Copyright:
© International Headache Society 2021.
PY - 2021/3
Y1 - 2021/3
N2 - The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.
AB - The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.
KW - Health technology assessment (HTA)
KW - International Headache Society (IHS)
KW - acute therapy
KW - migraine
KW - position statement
KW - preventive treatment
UR - http://www.scopus.com/inward/record.url?scp=85099866551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099866551&partnerID=8YFLogxK
U2 - 10.1177/0333102421989247
DO - 10.1177/0333102421989247
M3 - Article
C2 - 33472427
AN - SCOPUS:85099866551
SN - 0333-1024
VL - 41
SP - 279
EP - 293
JO - Cephalalgia
JF - Cephalalgia
IS - 3
ER -